Sanofi India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058A01010
  • NSEID: SANOFI
  • BSEID: 500674
INR
3,248.05
128.1 (4.11%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 58.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
SPARC
Innova Captab
Senores Pharma.
Supriya Lifesci.
Sudeep Pharma
Strides Pharma
Sanofi India
FDC
Blue Jet Health
Orchid Pharma
Aarti Pharma

Why is Sanofi India Ltd ?

1
Poor long term growth as Net Sales has grown by an annual rate of -9.00% and Operating profit at -7.95% over the last 5 years
2
Flat results in Mar 26
  • NO KEY NEGATIVE TRIGGERS
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -46.93% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sanofi India for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sanofi India
-46.93%
-2.45
19.17%
Sensex
-5.98%
-0.45
13.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-9.00%
EBIT Growth (5y)
-7.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
2.17
Tax Ratio
25.76%
Dividend Payout Ratio
65.08%
Pledged Shares
0
Institutional Holding
26.77%
ROCE (avg)
116.06%
ROE (avg)
43.30%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
11.13
EV to EBIT
17.07
EV to EBITDA
15.71
EV to Capital Employed
18.05
EV to Sales
4.09
PEG Ratio
NA
Dividend Yield
3.76%
ROCE (Latest)
116.18%
ROE (Latest)
48.73%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...